Overview
Oxytocin is a 9-amino acid cyclic neuropeptide synthesized in the hypothalamus and released from the posterior pituitary. Colloquially known as the 'love hormone' or 'bonding hormone,' it plays key roles in social bonding, trust, sexual behavior, childbirth, and lactation. FDA-approved as Pitocin for labor induction and postpartum hemorrhage prevention, intranasal oxytocin is widely researched for social cognition enhancement in autism spectrum disorder, PTSD, anxiety, and as a potential cognitive and relationship enhancer.
Mechanism of Action
Oxytocin binds G-protein coupled oxytocin receptors (OTR) expressed in the brain (limbic system, amygdala, hippocampus, nucleus accumbens), uterus, mammary glands, and heart. Central OTR activation modulates social behavior, trust, fear extinction (via amygdala inhibition), and dopamine/serotonin release in reward circuits. Peripheral OTR activation drives uterine contractions and milk letdown. Intranasal administration delivers oxytocin to the brain via olfactory and trigeminal pathways, bypassing the blood-brain barrier.
Potential Benefits
- FDA-approved for labor induction and postpartum hemorrhage
- Enhanced social bonding and trust behaviors
- Fear extinction and anxiety reduction via amygdala modulation
- Improved social cognition in autism spectrum disorder studies
- Potential benefits in PTSD (enhancing fear memory extinction)
- Analgesic effects
- Cardioprotective effects in some models
Dosage Protocols
The following reflects doses used in published research studies. This is not medical advice. Consult a qualified healthcare professional.
| Typical Range | 10-40 IU nasal; 1-3 IU subcutaneous |
| Beginner | 10-20 IU intranasal as needed |
| Intermediate | 24-40 IU intranasal daily |
| Advanced | 40 IU intranasal; 3-5 IU subcutaneous for enhanced effect |
| Cycle Duration | As needed or 4-8 week structured courses |
| Cycle Off | 2-4 weeks if used daily; receptor downregulation possible with continuous use |
Intranasal oxytocin is the most studied non-invasive route for CNS effects (social behavior, anxiety, bonding). IV oxytocin used clinically for labor induction (10-40 mIU/min). Subcutaneous research doses extrapolated from clinical data.
Use our Reconstitution Calculator to determine exact syringe units for your protocol.
Routes of Administration
Nasal Moderate
Primary route for neuropsychiatric and behavioral effects; 40 IU studied in behavioral research; onset within minutes
Subcutaneous Injection High
Used in research for peripheral effects; higher systemic bioavailability than intranasal
Intramuscular Injection High
Clinical use for postpartum hemorrhage; less common in research protocols
Read our full Routes of Administration Guide for detailed comparison of all delivery methods.
Stacking Protocols
Popular research stacks involving Oxytocin:
Sexual Health and Bonding Stack
Enhanced sexual function, arousal, and emotional bonding
Oxytocin deepens emotional connection and enhances orgasm intensity; PT-141 drives central sexual arousal; Kisspeptin elevates LH and testosterone.
Anti-Anxiety Stack
Social anxiety reduction and emotional regulation
Oxytocin reduces amygdala reactivity to social threats; Selank provides anxiolytic support through GABAergic modulation; complementary mechanisms for social anxiety.
Explore our complete Peptide Stacking Guide for more combinations and safety considerations.
Reconstitution
| Typical Vial Size | 10 IU/ml nasal spray, 10 IU/ml injectable solution |
|---|---|
| BAC Water | Typically supplied pre-formulated in sterile saline |
| Storage | Refrigerate at 2-8°C; protect from light |
| Shelf Life | Typically 24 months unopened; follow manufacturer guidance for opened vials |
Need exact syringe measurements?
Amino Acid Sequence
Cys-Tyr-Ile-Gln-Asn-Cys-Pro-Leu-Gly-NH2 (disulfide bridge Cys1-Cys6)
Side Effects & Safety
- Uterine hyperstimulation (obstetric use risk)
- Water retention and hyponatremia
- Nausea
- Potential anxiety augmentation in some individuals
- Headache
- Intranasal: nasal irritation
Synergistic Compounds
The following compounds have been studied alongside Oxytocin for potential complementary or synergistic effects: